Tweets with articles from #NephroWiki Twitter List 18 May 2015

Renal Biopsy 101: What you need to know #Nephpearls http://t.co/j1e8Wp56Ws pic.twitter.com/xuV0iWxoJf

— Edgar V. Lerma (@edgarvlermamd) May 19, 2015

Great article: The Urine Sediment as a Biomarker of Kidney Disease. http://t.co/11qKNs O4TP #ReadByQxMD

— Nephrology Now (@nephrologynow) May 19, 2015

Renal donors and future pregnancy https://t.co/tdlhctBXY4

— Amit Langote (@LangoteAmit) May 18, 2015

Therapeutic advantage of combination antihypertensive drug therapy using amlodipine & irbesartan in hypertensive pts http://t.co/ykZt7BEeK7

— Am Soc Ped Nephrol (@ASPNeph) May 18, 2015

Kidney Diseases Associated With Monoclonal Ig M–Secreting B-Cell Lymphoproliferative Ds: A Case Series http://t.co/4WzwbfoPWq cc @kdjhaveri

— AJKD blog (@AJKDblog) May 18, 2015

1st report of belatacept switch for CNI toxicity in HIGH RISK renal #transplant recipients: safe & effective but n=6 http://t.co/HGpEGd5D3O

— Paul Phelan (@paulphel) May 18, 2015

Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: A review http://t.co/Ypi4BLJjyR

— Am Soc Ped Nephrol (@ASPNeph) May 18, 2015

Aldo-DHF RCT: Spironolactone for Diastolic Heart Failure from @JAMA_current #NephJC Candiate? @kidney_boy @hswapnil http://t.co/eGQDKGNl9Q

— Edgar V. Lerma (@edgarvlermamd) May 17, 2015

Successful therapy of C3Nef-positive C3 glomerulopathy with plasma therapy and immunosuppression http://t.co/w3tj8MUeOc

— Am Soc Ped Nephrol (@ASPNeph) May 18, 2015

What are the latest trends in vascular access for dialysis? Dr. Ron Pisoni discusses the latest data here https://t.co/8ZtQM7n6Bk

— DOPPS (@DOPPStudy) May 18, 2015

Role of therapeutic plasmapheresis in ANCA-associated vasculitis http://t.co/8Z4PXuKjlR

— Am Soc Ped Nephrol (@ASPNeph) May 18, 2015

Familial syndromes associated with PHEOCHROMOCYTOMA #Nephpearls pic.twitter.com/6d9BJ4t0y3

— Edgar V. Lerma (@edgarvlermamd) May 18, 2015

Diagnosis & Management of PHEOCHROMOCYTOMA: Practical Guide #Nephpearls @LeachonTony http://t.co/30e2xwXPGH pic.twitter.com/gHaw7lawhn

— Edgar V. Lerma (@edgarvlermamd) May 18, 2015

Diagnosis and localization of PHEOCHROMOCYTOMA #Nephpearls @LeachonTony http://t.co/9NefpC3ojq pic.twitter.com/U4p9L0YE5M

— Edgar V. Lerma (@edgarvlermamd) May 18, 2015

Bringing the Benefits of High-Dose #Haemodialysis to the Home with a Novel Haemodialysis System. #Nephrology http://t.co/8RU7Wpceb1

— EMJ Nephrology (@EMJNephrology) May 18, 2015

#DabigatranOverdose- Urgent Management; Serious power of Twitter! @caioqualunque @edgarvlermamd @LangoteAmit @hswapnil @HekmagsMD @nephondemand

@hswapnil @edgarvlermamd @nephondemand going to hd my first dabigatran overdose. Do u have any advice?

— Fra Ian (@caioqualunque) May 15, 2015

@caioqualunque we had a ❓about that last year on the NOD+ 💬 https://t.co/2mXIgzeJxY #pradaxa #dabigatran 🆓 NOD+: http://t.co/WRZRbccxDx

— Tejas Desai, MD (@nephondemand) May 15, 2015

@caioqualunque Will PCC work, as thrombin is inhibited by Dabigatran? http://t.co/7tDat8AJtv

— Thahir (@docthahir) May 15, 2015

@docthahir off-label use, no definitive evidence, only anecdotal experience. PCC would work as a thrombin substitution therapy.

— Fra Ian (@caioqualunque) May 15, 2015

@caioqualunque SUSTAINED LOW EFFICIENCY hemodialysis for removal of dabigatran #Nephpearls http://t.co/HalfrVGiev pic.twitter.com/iQKOd3kEJR

— Edgar V. Lerma (@edgarvlermamd) May 15, 2015

@caioqualunque During HD, due to large Vd of dabigatran ➡️ Rebound in drug level #Nephpearls http://t.co/rvMoreC46i pic.twitter.com/SzMlfqzPEp

— Edgar V. Lerma (@edgarvlermamd) May 15, 2015

@caioqualunque @edgarvlermamd @HekmagsMD Needed around 4 sessions of conventional HD to get INR closer to safe range.

— Amit Langote (@LangoteAmit) May 15, 2015

@caioqualunque @hswapnil @edgarvlermamd @nephondemand FEIBA is also recommended prior to catheter placement. Again, just anecdotal cases

— Hector Madariaga (@HekmagsMD) May 15, 2015

@nephondemand @HekmagsMD @caioqualunque antagonizes factor VIII inhibitor http://t.co/b98433v1R0 pic.twitter.com/Q5H9TJOjvV

— Swapnil Hiremath, MD (@hswapnil) May 15, 2015

@nephondemand @caioqualunque FEIBA ( Factor Eight Inhibitor Bypass Activity) http://t.co/UmnGlLgTHG

— Hector Madariaga (@HekmagsMD) May 15, 2015

@caioqualunque @edgarvlermamd A good review in CJASN on Dabigatran and kidney with flowchart for Toxicity https://t.co/9o6EWKaJqI

— Amit Langote (@LangoteAmit) May 15, 2015

@caioqualunque Approach to Dabigatran associated bleeding #Nephpearls http://t.co/m2dfKq7uyp Thanks @LangoteAmit pic.twitter.com/AFrp6E4b5h

— Edgar V. Lerma (@edgarvlermamd) May 16, 2015

Today on #NephroWiki Twitter List May 14 2015

RENIN PROFILING HIGH RENIN: ACE-I, Beta Blockers - Whites LOW RENIN: CCBs, Diuretics - Blacks, Elderly #Nephpearls pic.twitter.com/L2nW5fLnIy

— Edgar V. Lerma (@edgarvlermamd) May 15, 2015

LOW RENIN HYPERTENSION #Nephpearls http://t.co/p6lLn86ODm pic.twitter.com/d7ifrDWg3s

— Edgar V. Lerma (@edgarvlermamd) May 15, 2015

Monogenic forms of hypertension #Nephpearls http://t.co/DH0i0CR62u pic.twitter.com/c2R4oEEgPl

— Edgar V. Lerma (@edgarvlermamd) May 15, 2015

@kidney_boy Associated conditions and Renal Tubular Acidosis (RTA) from @MedStudy #Nephpearls @Medicalmnemonic pic.twitter.com/6lCoy9pbmZ

— Edgar V. Lerma (@edgarvlermamd) May 15, 2015

Good read on hypokalemia + met alkalosis (Respect the URINE K) #Nephpearls http://t.co/6mb9Ujfz0T pic.twitter.com/yinifWuTL7

— Edgar V. Lerma (@edgarvlermamd) May 15, 2015

How to differentiate TB from non-TB pleural effusions in CKD. https://t.co/OPJm69Yxcb pic.twitter.com/DzpH6Xk80I

— Vivek Jha (@vjha126) May 15, 2015

As if I'm somehow not a fan of Bactrim. Oh wait. http://t.co/OTsxg7hawZ https://t.co/1tJL3vX3GG

— David Juurlink (@DavidJuurlink) May 14, 2015

Diabetes-related end-stage renal disease in Austria 1965–2013 http://t.co/0ciUPqJ2Qt

— Am Soc Ped Nephrol (@ASPNeph) May 14, 2015

Low Vit D and High Fibroblast Growth Factor 23 Serum Levels Asso w/ Infectious & Cardiac Deaths in the HEMO Study http://t.co/lcbs2h3nAv

— Am Soc Ped Nephrol (@ASPNeph) May 14, 2015

Transplant-Related Costs Incurred by Living Kidney Donors - RUN http://t.co/kYbebliMc5

— Am Soc Ped Nephrol (@ASPNeph) May 14, 2015

Characteristics and Outcomes of AKI Treated with #Dialysis during Pregnancy and the Postpartum Period http://t.co/hYBfuVUGXK

— Am Soc Ped Nephrol (@ASPNeph) May 14, 2015

Characteristics and Outcomes of AKI Treated with #Dialysis during Pregnancy and the Postpartum Period http://t.co/hYBfuVUGXK

— Am Soc Ped Nephrol (@ASPNeph) May 14, 2015

The Renin-Angiotensin and Renal Dopaminergic Systems Interact in Normotensive Humans http://t.co/bEczQ0dh0y

— Am Soc Ped Nephrol (@ASPNeph) May 14, 2015

Renal function can be impaired in children with primary hyperoxaluria type 3 http://t.co/oTXO754xcO

— Am Soc Ped Nephrol (@ASPNeph) May 14, 2015

Measuring GFR in the ICU: Best Practices? http://t.co/bGQ6SZZ9QQ

— Medscape Kidney (@MedscapeKidney) May 14, 2015

Effects of #calcineurin and mTOR #inhibitors on #alloreactive Th1, Th17 & regulatory T #cells. http://t.co/pOD9Si3FCu pic.twitter.com/8ZnJm8ZZlN

— Transplantation (@TransplantJrnl) May 14, 2015

Study investigates the quality of #organs from potential #donors with #HIV http://t.co/0A1aXteHH3

— Am Soc Nephrology (@ASNKidney) May 14, 2015

Precise #renal function measurement is critical to forecast adverse outcomes after nephrectomy http://t.co/DJc2r4uoqI pic.twitter.com/o1XQSDLZSY

— Cleveland Clinic MD (@CleClinicMD) May 9, 2015

Cochrane review. Terlipressin for HRS http://t.co/9iqvquEyW6 47%% mortality in pt on Terli+alb vs 63% placebo+alb #nephjc

— Hector Madariaga (@HekmagsMD) May 13, 2015